We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-1.45%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$551M
AUM Growth
-$18M
Cap. Flow
-$3.48M
Cap. Flow %
-0.63%
Top 10 Hldgs %
36.14%
Holding
161
New
13
Increased
35
Reduced
76
Closed
17

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$6.58M
2
HAL icon
Halliburton
HAL
+$2.97M
3
DAN icon
Dana Inc
DAN
+$2.79M
4
ELAN icon
Elanco Animal Health
ELAN
+$2.72M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.68M

Sector Composition

Rank Sector Weight
1 Industrials 25.67%
2 Healthcare 25.14%
3 Technology 17.68%
4 Miscellaneous 8.37%
5 Utilities 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
1
Emerson Electric
EMR
$86.6B
$41.6M 7.55%
621,807
+33,019
+6% +$2.08M
XOM icon
2
ExxonMobil
XOM
$644B
$25M 4.53%
353,425
-72,048
-17% -$5.21M
GLW icon
3
Corning
GLW
$128B
$24.2M 4.4%
848,915
+66,405
+8% +$1.99M
BMY icon
4
Bristol-Myers Squibb
BMY
$136B
$21.1M 3.82%
415,228
+56,960
+16% +$2.68M
PFE icon
5
Pfizer
PFE
$159B
$16.5M 3%
485,233
+25,891
+6% +$941K
INTC icon
6
Intel
INTC
$473B
$15.6M 2.84%
303,646
-4,080
-1% -$201K
GVA icon
7
Granite Construction
GVA
$5.44B
$14.1M 2.56%
438,325
-141,000
-24% -$4.89M
NVS icon
8
Novartis
NVS
$292B
$13.7M 2.5%
158,125
-675
-0.4% -$60.6K
GSK icon
9
GSK
GSK
$102B
$13.6M 2.47%
255,240
+6,260
+3% +$322K
MMM icon
10
3M
MMM
$89.9B
$13.6M 2.46%
98,578
+47,063
+91% +$6.58M
OGE icon
11
OGE Energy
OGE
$9.45B
$12.9M 2.34%
283,968
-6,575
-2% -$285K
JNJ icon
12
Johnson & Johnson
JNJ
$646B
$12.1M 2.2%
93,498
-1,707
-2% -$225K
EEMV icon
13
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.65B
$11.8M 2.15%
207,239
-1,600
-0.8% -$92K
LGTY
14
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$11.6M 2.1%
770,867
-10,034
-1% -$141K
XRAY icon
15
Dentsply Sirona
XRAY
$2.22B
$11.6M 2.1%
216,950
-3,650
-2% -$196K
BCE icon
16
BCE
BCE
$21.9B
$11.1M 2.02%
230,251
-5,243
-2% -$245K
FLS icon
17
Flowserve
FLS
$10.2B
$11M 2.01%
236,497
+3,212
+1% +$152K
MDU icon
18
MDU Resources
MDU
$4.16B
$11M 1.99%
1,023,806
-16,658
-2% -$170K
LNN icon
19
Lindsay Corp
LNN
$1.16B
$11M 1.99%
118,148
-2,250
-2% -$201K
MSFT icon
20
Microsoft
MSFT
$3.81T
$9.71M 1.76%
69,868
-330
-0.5% -$45.4K
BNS icon
21
Scotiabank
BNS
$113B
$9.12M 1.66%
160,500
+3,650
+2% +$196K
HON icon
22
Honeywell
HON
$68.9B
$8.15M 1.48%
51,121
-637
-1% -$101K
ABT icon
23
Abbott
ABT
$195B
$7.47M 1.36%
89,238
-746
-0.8% -$63.4K
TEL icon
24
TE Connectivity
TEL
$58.7B
$7.32M 1.33%
78,600
-550
-0.7% -$50.6K
TMO icon
25
Thermo Fisher Scientific
TMO
$230B
$7.24M 1.32%
24,857
-587
-2% -$168K

Similar funds

John G. Ullman & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, John G. Ullman & Associates held 161 positions worth $551M, down 3.2% from $569M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

John G. Ullman & Associates's Q3 2019 filing shows 13 new, 35 increased, 76 reduced and 17 closed positions. Its largest new stake was Dana Inc: 179,800 shares worth $2.6M. The largest sale was Evergy, an estimated $9.16M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

  • John G. Ullman & Associates's largest Q3 2019 buy was Dana Inc: 179,800 shares worth $2.6M.
  • John G. Ullman & Associates added most to 3M in Q3 2019, an estimated $6.58M increase.
  • John G. Ullman & Associates's biggest Q3 2019 reduction was ExxonMobil, cutting an estimated $5.21M.
  • John G. Ullman & Associates fully exited Evergy in Q3 2019, selling an estimated $9.16M.
  • John G. Ullman & Associates's ten largest holdings make up 36% of its $551M portfolio in Q3 2019.
  • John G. Ullman & Associates opened 13 new positions and closed 17 in Q3 2019.
  • John G. Ullman & Associates's portfolio value fell 3.2% quarter-over-quarter to $551M.

Based on John G. Ullman & Associates's 13F filing for Q3 2019, filed 21 Oct 2019.